Cargando…
Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs
Effective management of pain in animals is of critical importance but options are limited for treating acute pain in dogs on an outpatient basis. The objective of this study was to compare the plasma concentrations and pharmacokinetics of a concentrated solution of buprenorphine, 1.8 mg/ml (Simbadol...
Autores principales: | Enomoto, Hiroko, Love, Lydia, Madsen, Melanie, Wallace, Amber, Messenger, Kristen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543267/ https://www.ncbi.nlm.nih.gov/pubmed/35445748 http://dx.doi.org/10.1111/jvp.13056 |
Ejemplares similares
-
Pharmacokinetic Characterisation and Comparison of Bioavailability of Intranasal Fentanyl, Transmucosal, and Intravenous Administration through a Three-Way Crossover Study in 24 Healthy Volunteers
por: Nardi-Hiebl, S., et al.
Publicado: (2021) -
Transmucosal Buprenorphine in the Treatment of Dyspnea: Case Series and Review of the Literature
por: Blumenfeld-Kouchner, François, et al.
Publicado: (2021) -
Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs
por: della Rocca, Giorgia, et al.
Publicado: (2023) -
Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity
por: Hartwell, Brittany L., et al.
Publicado: (2022) -
Pharmacokinetics of buprenorphine in pregnant sheep after intravenous injection
por: Hakomäki, Henriikka, et al.
Publicado: (2021)